Defective cholesterol metabolism in amyotrophic lateral sclerosis[S]

As neurons die, cholesterol is released in the central nervous system (CNS); hence, this sterol and its metabolites may represent a biomarker of neurodegeneration, including in amyotrophic lateral sclerosis (ALS), in which altered cholesterol levels have been linked to prognosis. More than 40 different sterols were quantified in serum and cerebrospinal fluid (CSF) from ALS patients and healthy controls. In CSF, the concentration of cholesterol was found to be elevated in ALS samples. When CSF metabolite levels were normalized to cholesterol, the cholesterol metabolite 3β,7α-dihydroxycholest-5-en-26-oic acid, along with its precursor 3β-hydroxycholest-5-en-26-oic acid and product 7α-hydroxy-3-oxocholest-4-en-26-oic acid, were reduced in concentration, whereas metabolites known to be imported from the circulation into the CNS were not found to differ in concentration between groups. Analysis of serum revealed that (25R)26-hydroxycholesterol, the immediate precursor of 3β-hydroxycholest-5-en-26-oic acid, was reduced in concentration in ALS patients compared with controls. We conclude that the acidic branch of bile acid biosynthesis, known to be operative in-part in the brain, is defective in ALS, leading to a failure of the CNS to remove excess cholesterol, which may be toxic to neuronal cells, compounded by a reduction in neuroprotective 3β,7α-dihydroxycholest-5-en-26-oic acid.

[1]  C. Betsholtz,et al.  Effects of a Disrupted Blood-Brain Barrier on Cholesterol Homeostasis in the Brain* , 2014, The Journal of Biological Chemistry.

[2]  N. Javitt,et al.  27-Hydroxycholesterol, does it exist? On the nomenclature and stereochemistry of 26-hydroxylated sterols , 2012, Steroids.

[3]  P. Clayton,et al.  Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  U. Diczfalusy,et al.  Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. , 1995, Analytical biochemistry.

[5]  P. Andersen,et al.  Cholesterol, Oxysterol, Triglyceride, and Coenzyme Q Homeostasis in ALS. Evidence against the Hypothesis That Elevated 27-Hydroxycholesterol Is a Pathogenic Factor , 2014, PloS one.

[6]  F. Pfrieger,et al.  Cholesterol metabolism in neurons and astrocytes. , 2011, Progress in lipid research.

[7]  F. Violi,et al.  Measurement of oxysterols and alpha-tocopherol in plasma and tissue samples as indices of oxidant stress status. , 2003, Analytical biochemistry.

[8]  L. H. van den Berg,et al.  Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  L. Wahlund,et al.  Diagnostic use of cerebral and extracerebral oxysterols , 2004, Clinical chemistry and laboratory medicine.

[10]  M. Eriksson,et al.  Patients with atherosclerosis may have increased circulating levels of 27‐hydroxycholesterol and cholestenoic acid , 2005, Scandinavian journal of clinical and laboratory investigation.

[11]  P. Schultz,et al.  Oxysterols direct immune cell migration via EBI2 , 2011, Nature.

[12]  L. Karlsson,et al.  Oxysterols direct B-cell migration through EBI2 , 2011, Nature.

[13]  N. Grishin,et al.  Direct Demonstration That Loop1 of Scap Binds to Loop7 , 2016, The Journal of Biological Chemistry.

[14]  Eoin Fahy,et al.  Metabolomics Workbench: An international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools , 2015, Nucleic Acids Res..

[15]  W. Griffiths,et al.  The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome. , 2008, Journal of proteome research.

[16]  H. Shang,et al.  Statins and amyotrophic lateral sclerosis: a systematic review and meta-analysis , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[17]  S. Ferdinandusse,et al.  Bile acids: the role of peroxisomes , 2009, Journal of Lipid Research.

[18]  I. Björkhem.  Five decades with oxysterols. , 2013, Biochimie.

[19]  O. Hardiman,et al.  Amyotrophic lateral sclerosis , 2011, The Lancet.

[20]  L. Wahlund,et al.  Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases , 2000, Neuroscience Letters.

[21]  Wolfgang Sattler,et al.  Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7α-hydroxy-3-oxo-4-cholestenoic acid Published, JLR Papers in Press, January 24, 2007. , 2007, Journal of Lipid Research.

[22]  Steve Meaney,et al.  Crossing the barrier: Published, JLR Papers in Press, March 1, 2005. DOI 10.1194/jlr.M500024-JLR200 net flux of 27-hydroxycholesterol into the human brain , 2005, Journal of Lipid Research.

[23]  J. Gustafsson,et al.  Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  V. Meininger,et al.  Dyslipidemia is a protective factor in amyotrophic lateral sclerosis , 2008, Neurology.

[25]  J. Gustafsson,et al.  Liver X receptor β (LXRβ): A link between β-sitosterol and amyotrophic lateral sclerosis–Parkinson's dementia , 2008, Proceedings of the National Academy of Sciences.

[26]  P. Clayton,et al.  Disorders of bile acid synthesis , 2006, Journal of Inherited Metabolic Disease.

[27]  D. Russell.  The enzymes, regulation, and genetics of bile acid synthesis. , 2003, Annual review of biochemistry.

[28]  Albert Ludolph,et al.  Mechanisms, models and biomarkers in amyotrophic lateral sclerosis , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[29]  R. Schüle,et al.  Cholestenoic acids regulate motor neuron survival via liver X receptors. , 2014, The Journal of clinical investigation.

[30]  Patrick Emond,et al.  Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry. , 2013, Journal of proteome research.

[31]  P. Andersen,et al.  Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS , 2011, PloS one.

[32]  I. Björkhem.  Rediscovery of Cerebrosterol , 2007, Lipids.

[33]  P. Tontonoz,et al.  Liver X receptors as integrators of metabolic and inflammatory signaling. , 2006, The Journal of clinical investigation.

[34]  Andrew Lockhart,et al.  Cerebrospinal Fluid Steroidomics: Are Bioactive Bile Acids Present in Brain?* , 2009, The Journal of Biological Chemistry.

[35]  Alok Kumar,et al.  Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[36]  R. Evans,et al.  Nuclear Receptors, RXR, and the Big Bang , 2014, Cell.

[37]  J. Gustafsson.  Control of gene expression by novel metabolic intermediates , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[38]  J. Gustafsson,et al.  Neuropathologic and Biochemical Changes During Disease Progression in Liver X Receptor &bgr;−/− Mice, A Model of Adult Neuron Disease , 2010, Journal of neuropathology and experimental neurology.

[39]  M. Turner,et al.  Inflammation and neurovascular changes in amyotrophic lateral sclerosis , 2013, Molecular and Cellular Neuroscience.

[40]  W. Griffiths,et al.  Cholesterol metabolites exported from human brain , 2015, Steroids.

[41]  J. Kassubek,et al.  Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis , 2011, Journal of Neurology.

[42]  E. Baulieu,et al.  Metabolism of 27-, 25- and 24-hydroxycholesterol in rat glial cells and neurons. , 1997, The Biochemical journal.

[43]  J. Dietschy,et al.  Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.R400004-JLR200 , 2004, Journal of Lipid Research.

[44]  M. Mattson,et al.  Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress–induced death of motor neurons in amyotrophic lateral sclerosis , 2002, Annals of neurology.

[45]  D. Russell,et al.  25-Hydroxycholesterol suppresses interleukin-1–driven inflammation downstream of type I interferon , 2014, Science.

[46]  William J Griffiths,et al.  Analytical strategies for characterization of oxysterol lipidomes: liver X receptor ligands in plasma. , 2013, Free radical biology & medicine.

[47]  Joseph L. Goldstein,et al.  Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Oxysterols block transport by binding to Insig , 2007, Proceedings of the National Academy of Sciences.

[48]  M. Turner,et al.  The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis , 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[49]  D. Russell,et al.  Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. , 2009, Annual review of biochemistry.

[50]  C. Glass,et al.  A comprehensive classification system for lipids. , 2005, Journal of lipid research.

[51]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.

[52]  Ewout J. N. Groen,et al.  Mapping of Gene Expression Reveals CYP27A1 as a Susceptibility Gene for Sporadic ALS , 2012, PloS one.

[53]  Patrick Emond,et al.  1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis , 2010, PloS one.

[54]  P. Clayton,et al.  Quantitative charge-tags for sterol and oxysterol analysis. , 2015, Clinical chemistry.